Parslow James F

Parslow James F is listed in filings as Interim CEO and CFO at Xenetic Biosciences, Inc.. This profile follows SEC Form 4 activity through Apr 23, 2026, including 2 public disclosures. Recent filings connect the profile to Xenetic Biosciences, Inc. (XBIO). The current snapshot covers public activity from Jun 21, 2024 to Apr 23, 2026. Reported amounts are shown as $79.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.